These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32761807)

  • 1. The role of mitochondrial proteases in leukemic cells and leukemic stem cells.
    Mirali S; Schimmer AD
    Stem Cells Transl Med; 2020 Dec; 9(12):1481-1487. PubMed ID: 32761807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability.
    Mirali S; Botham A; Voisin V; Xu C; St-Germain J; Sharon D; Hoff FW; Qiu Y; Hurren R; Gronda M; Jitkova Y; Nachmias B; MacLean N; Wang X; Arruda A; Minden MD; Horton TM; Kornblau SM; Chan SM; Bader GD; Raught B; Schimmer AD
    Sci Transl Med; 2020 Apr; 12(538):. PubMed ID: 32269163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting mitochondrial proteases for therapy of acute myeloid leukaemia.
    Xiang X; Bao R; Wu Y; Luo Y
    Br J Pharmacol; 2022 Jul; 179(13):3268-3282. PubMed ID: 35352341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis.
    Greer YE; Hernandez L; Fennell EMJ; Kundu M; Voeller D; Chari R; Gilbert SF; Gilbert TSK; Ratnayake S; Tang B; Hafner M; Chen Q; Meerzaman D; Iwanowicz E; Annunziata CM; Graves LM; Lipkowitz S
    Cancer Res Commun; 2022 Oct; 2(10):1144-1161. PubMed ID: 36388465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.
    Akiyama H; Zhao R; Ostermann LB; Li Z; Tcheng M; Yazdani SJ; Moayed A; Pryor ML; Slngh S; Baran N; Ayoub E; Nishida Y; Mak PY; Ruvolo VR; Carter BZ; Schimmer AD; Andreeff M; Ishizawa J
    Leukemia; 2024 Apr; 38(4):729-740. PubMed ID: 38148395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mitochondrial respiration for the treatment of acute myeloid leukemia.
    Carter JL; Hege K; Kalpage HA; Edwards H; Hüttemann M; Taub JW; Ge Y
    Biochem Pharmacol; 2020 Dec; 182():114253. PubMed ID: 33011159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compounds as human ClpP agonists.
    Zhang R; Wang P; Wei B; Chen L; Song X; Pan Y; Li J; Gan J; Zhang T; Yang CG
    Eur J Med Chem; 2023 Oct; 258():115577. PubMed ID: 37352796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of SAM50 Specifically Targets BCR-ABL-Expressing Leukemic Stem and Progenitor Cells by Interfering with Mitochondrial Functions.
    Capala ME; Pruis M; Vellenga E; Schuringa JJ
    Stem Cells Dev; 2016 Mar; 25(5):427-37. PubMed ID: 26855047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia.
    Cole A; Wang Z; Coyaud E; Voisin V; Gronda M; Jitkova Y; Mattson R; Hurren R; Babovic S; Maclean N; Restall I; Wang X; Jeyaraju DV; Sukhai MA; Prabha S; Bashir S; Ramakrishnan A; Leung E; Qia YH; Zhang N; Combes KR; Ketela T; Lin F; Houry WA; Aman A; Al-Awar R; Zheng W; Wienholds E; Xu CJ; Dick J; Wang JC; Moffat J; Minden MD; Eaves CJ; Bader GD; Hao Z; Kornblau SM; Raught B; Schimmer AD
    Cancer Cell; 2015 Jun; 27(6):864-76. PubMed ID: 26058080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting neurolysin in acute myeloid leukemia.
    Mirali S; Schimmer AD
    Mol Cell Oncol; 2020; 7(4):1761243. PubMed ID: 32944624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia.
    Yehudai D; Liyanage SU; Hurren R; Rizoska B; Albertella M; Gronda M; Jeyaraju DV; Wang X; Barghout SH; MacLean N; Siriwardena TP; Jitkova Y; Targett-Adams P; Schimmer AD
    Haematologica; 2019 May; 104(5):963-972. PubMed ID: 30573504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.
    Di Marcantonio D; Martinez E; Sidoli S; Vadaketh J; Nieborowska-Skorska M; Gupta A; Meadows JM; Ferraro F; Masselli E; Challen GA; Milsom MD; Scholl C; Fröhling S; Balachandran S; Skorski T; Garcia BA; Mirandola P; Gobbi G; Garzon R; Vitale M; Sykes SM
    Clin Cancer Res; 2018 Feb; 24(3):608-618. PubMed ID: 29127121
    [No Abstract]   [Full Text] [Related]  

  • 14. All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.
    Nguyen CH; Bauer K; Hackl H; Schlerka A; Koller E; Hladik A; Stoiber D; Zuber J; Staber PB; Hoelbl-Kovacic A; Purton LE; Grebien F; Wieser R
    Cell Death Dis; 2019 Dec; 10(12):944. PubMed ID: 31822659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
    Schinke C; Giricz O; Li W; Shastri A; Gordon S; Barreyro L; Bhagat T; Bhattacharyya S; Ramachandra N; Bartenstein M; Pellagatti A; Boultwood J; Wickrema A; Yu Y; Will B; Wei S; Steidl U; Verma A
    Blood; 2015 May; 125(20):3144-52. PubMed ID: 25810490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells.
    Hatfield KJ; Reikvam H; Bruserud Ø
    Expert Opin Ther Targets; 2014 Nov; 18(11):1237-51. PubMed ID: 25200484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
    Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
    Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia.
    Yang XH; Li M; Wang B; Zhu W; Desgardin A; Onel K; de Jong J; Chen J; Chen L; Cunningham JM
    BMC Bioinformatics; 2015 Mar; 16():97. PubMed ID: 25887548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.